[1] Gerbase AC, Rowley JT, Heymann DH, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect, 1998, 74 Suppl 1:S12-S16.
[2] Low N, Daker-White G, Barlow D, et al.Gonorrhoea in inner London: results of a cross sectional study. BMJ, 1997, 314:1719-1723.
[3] Roche P, Spencer J, Lin M, et al. Australia's notifiable diseases status, 1999: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell,2001, 25:190-245.
[4] Martin IM, Ison CA. Rise in gonorrhoea in London, UK. London Gonococcal Working Group. Lancet, 2000, 355:623.
[5] Donovan B, Bodsworth NJ, Rohrsheim R,et al. Increasing gonorrhoea reports--not only in London. Lancet, 2000, 355:1908.
[6] Waugh MA. Task force for the urgent response to the epidemics of sexually transmitted diseases in eastern Europe and central Asia. Sex Transm Infect, 1999, 75:72-73.
[7] Cohen MS, Hoffman IF, Royce RA, et al.Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet, 1997, 349:1868-1873.
[8] Haizlip J, Isbey SF, Hamilton HA, et al.Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy. Sex Transm Dis, 1995, 22:145-148.
[9] Backman M, Jacobson K, Ringertg S. The virgin population of Neisseria gonorrhoeae in Stockhom has decreased and antimicrobial resistance is increasing. Genitourin Med, 1996, 71: 234-238.
[10] Mayaud P, Hawkes S, Mabey D. et al. Advances in control of sexually transmitted diseases in developing countries. Lancet,1998, 351:29-32.
[11] Tapsall J W. The biology of Neisseria gonorrhoeae: a model of adaptation and survival. Venereology, 2000, 13:63-69.
[12] 叶顺章.淋球菌对抗生索的耐药性监测.中国性病艾滋病防治,2001,7:123-125.
[13] No authors listed. 1998 guidelines for treatment of sexually transmitted diseases.Centers for Disease Control and Prevention. MMWR Recomm Rep, 1998, 47:1-111.
[14] Muratani T, Akasaka S, Kobayashi T, et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother, 2001, 45:3603-3606.
[15] Belland RJ, Morrison SG, Ison C, et al.Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol, 1994, 14:371-380.
[16] Shultz TR, Tapsall JW, White PA. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.Antimicrob Agents Chemother, 2001, 45:734-738.
[17] 李珊山,刘鹤松,钟淑侠,等.淋球菌对环丙沙星的耐药性及耐药机制的研究.中华皮肤科杂志,2000,33:275-276.
[18] 苏晓红,戴秀芹,叶顺章.氟喹诺酮类药物治疗淋病失败8例报道.中国性病艾滋病防治,2001,增刊:612-613.
[19] Tapsall JW, Shultz TR, Limnios EA, et al.Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. Sex Transm Dis, 1998, 25:505-508.
[20] Dillon JA, Rubabaza JP, Benzaken AS, et al. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.Sex Transm Dis, 2001, 28:521-526.
[21] Turner A, Gough KR, Leeming JP. Molecular epidemiology of tetM genes in Neisseria gonorrhoeae. Sex Transm Infect, 1999,75:60-66.
[22] Ison CA. Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing. Genitourin Med,1996, 72:253-257.
[23] Djajakusumah T, Sudigdoadi S, Meheus A,et al. Plasmid patterns and antimicrobial susceptibilities of Neisseria gonorrhoeae in Bandung, Indonesia. Trans R Soc Trop Med Hyg, 1998, 92:105-107.
[24] Lkhamsuren E, Shultz TR, Limnios EA, et al. The antibiotic susceptibility of Neisseria gonorrhoeae isolated in Ulaanbaatar,Mongolia. Sex Transm Infect, 2001, 77:218-219.
[25] Bhalla P, Sethi K, Reddy BS, et al. Antimicrobial susceptibility and plasmid profile of Neisseria gonorrhoeae in India (New Delhi). Sex Transm Infect, 1998,74:210-212.
[26] 叶顺章,苏晓红,王千秋,等.1993～1998年中国十城市分离的淋球菌对抗生素的敏感性监测.中华皮肤科杂志,2001,34:175-177.
[27] 曹文苓,宋卫忠,黎小东,等.广州地区淋球菌对5种抗生素的耐药性结果分析.中国麻风皮肤病杂志,2002,18:136-137.
[28] Barbosa-Cesnik CT, Gerbase A, Heymann D. STD vaccines--an overview. Genitourin Med, 1997, 73:336-342. |
